These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35426038)

  • 1. Dickkopf1 (Dkk1) Alleviates Vascular Calcification by Regulating the Degradation of Phospholipase D1 (PLD1).
    Li X; Liu XL; Li X; Zhao YC; Wang QQ; Zhong HY; Liu DD; Yuan C; Zheng TF; Zhang M
    J Cardiovasc Transl Res; 2022 Dec; 15(6):1327-1339. PubMed ID: 35426038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase D: A new mediator during high phosphate-induced vascular calcification associated with chronic kidney disease.
    Skafi N; Abdallah D; Soulage C; Reibel S; Vitale N; Hamade E; Faour W; Magne D; Badran B; Hussein N; Buchet R; Brizuela L; Mebarek S
    J Cell Physiol; 2019 Apr; 234(4):4825-4839. PubMed ID: 30207376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ameliorative effect of terpinen-4-ol on ER stress-induced vascular calcification depends on SIRT1-mediated regulation of PERK acetylation.
    Zhang Y; He L; Tu M; Huang M; Chen Y; Pan D; Peng J; Shen X
    Pharmacol Res; 2021 Aug; 170():105629. PubMed ID: 34089864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells.
    Choi SY; Ryu HM; Oh EJ; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    PLoS One; 2017; 12(7):e0180393. PubMed ID: 28686724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt1 inhibits vascular smooth muscle cell calcification by promoting ANKH expression.
    Chen B; Zhao Y; Han D; Zhao B; Mao Y; Cui ZK; Chu YC; Feng L; Yin S; Wang CY; Wang X; Xu MJ; Zhao G
    J Mol Cell Cardiol; 2019 Oct; 135():10-21. PubMed ID: 31356809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shh-Gli2-Runx2 inhibits vascular calcification.
    Huang A; Xu T; Lu X; Ma L; Ma H; Yu Y; Yao L
    Nephrol Dial Transplant; 2024 Jan; 39(2):305-316. PubMed ID: 37451818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation.
    Zhao Y; Zhao MM; Cai Y; Zheng MF; Sun WL; Zhang SY; Kong W; Gu J; Wang X; Xu MJ
    Kidney Int; 2015 Oct; 88(4):711-21. PubMed ID: 26061549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium-glucose cotransporter 2 inhibitor canagliflozin alleviates vascular calcification through suppression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 inflammasome.
    Chen A; Lan Z; Li L; Xie L; Liu X; Yang X; Wang S; Liang Q; Dong Q; Feng L; Li Y; Ye Y; Fu M; Lu L; Yan J
    Cardiovasc Res; 2023 Oct; 119(13):2368-2381. PubMed ID: 37523743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor inhibition prevents vascular calcifying extracellular vesicle biogenesis.
    Bakhshian Nik A; Ng HH; Ashbrook SK; Sun P; Iacoviello F; Shearing PR; Bertazzo S; Mero D; Khomtchouk BB; Hutcheson JD
    Am J Physiol Heart Circ Physiol; 2023 Apr; 324(4):H553-H570. PubMed ID: 36827229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TDAG51 (T-Cell Death-Associated Gene 51) Is a Key Modulator of Vascular Calcification and Osteogenic Transdifferentiation of Arterial Smooth Muscle Cells.
    Platko K; Lebeau PF; Gyulay G; Lhoták Š; MacDonald ME; Pacher G; Hyun Byun J; Boivin FJ; Igdoura SA; Cutz JC; Bridgewater D; Ingram AJ; Krepinsky JC; Austin RC
    Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1664-1679. PubMed ID: 32434409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OGT knockdown counteracts high phosphate-induced vascular calcification in chronic kidney disease through autophagy activation by downregulating YAP.
    Xu TH; Sheng Z; Li Y; Qiu X; Tian B; Yao L
    Life Sci; 2020 Nov; 261():118121. PubMed ID: 32693242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular Calcification Induced by Chronic Kidney Disease Is Mediated by an Increase of 1α-Hydroxylase Expression in Vascular Smooth Muscle Cells.
    Torremadé N; Bozic M; Panizo S; Barrio-Vazquez S; Fernandez-Martín JL; Encinas M; Goltzman D; Arcidiacono MV; Fernandez E; Valdivielso JM
    J Bone Miner Res; 2016 Oct; 31(10):1865-1876. PubMed ID: 27074284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Klotho/FGF23 axis mediates high phosphate-induced vascular calcification in vascular smooth muscle cells via Wnt7b/β-catenin pathway.
    Chen YX; Huang C; Duan ZB; Xu CY; Chen Y
    Kaohsiung J Med Sci; 2019 Jul; 35(7):393-400. PubMed ID: 31001900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D Receptor From VSMCs Regulates Vascular Calcification During CKD: A Potential Role for miR-145a.
    Caus M; Alonso-Montes C; Fernandez-Martin JL; Marti-Antonio M; Bozic M; Valdivielso JM
    Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1533-1548. PubMed ID: 37381989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating uromodulin inhibits vascular calcification by interfering with pro-inflammatory cytokine signalling.
    Alesutan I; Luong TTD; Schelski N; Masyout J; Hille S; Schneider MP; Graham D; Zickler D; Verheyen N; Estepa M; Pasch A; Maerz W; Tomaschitz A; Pilz S; Frey N; Lang F; Delles C; Müller OJ; Pieske B; Eckardt KU; Scherberich J; Voelkl J
    Cardiovasc Res; 2021 Feb; 117(3):930-941. PubMed ID: 32243494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GALNT3 protects against phosphate-induced calcification in vascular smooth muscle cells by enhancing active FGF23 and inhibiting the wnt/β-catenin signaling pathway.
    Guo L; Wang Y; Li S; Zhou L; Li D
    Cell Signal; 2022 Dec; 100():110477. PubMed ID: 36162588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of vascular smooth muscle cell calcification by vasorin through interference with TGFβ1 signaling.
    Luong TTD; Estepa M; Boehme B; Pieske B; Lang F; Eckardt KU; Voelkl J; Alesutan I
    Cell Signal; 2019 Dec; 64():109414. PubMed ID: 31505229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apelin-13 attenuates high glucose-induced calcification of MOVAS cells by regulating MAPKs and PI3K/AKT pathways and ROS-mediated signals.
    Zhang P; Wang AP; Yang HP; Ai L; Zhang HJ; Wang YM; Bi YL; Fan HH; Gao J; Zhang HY; Liu JZ
    Biomed Pharmacother; 2020 Aug; 128():110271. PubMed ID: 32450527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK1/2 inhibition reduces vascular calcification by activating miR-126-3p-DKK1/LRP6 pathway.
    Zeng P; Yang J; Liu L; Yang X; Yao Z; Ma C; Zhu H; Su J; Zhao Q; Feng K; Yang S; Zhu Y; Li X; Wang W; Duan Y; Han J; Chen Y
    Theranostics; 2021; 11(3):1129-1146. PubMed ID: 33391525
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombomodulin, a novel molecule regulating inorganic phosphate-induced vascular smooth muscle cell calcification.
    Son BK; Akishita M; Iijima K; Ogawa S; Arai T; Ishii H; Maemura K; Aburatani H; Eto M; Ouchi Y
    J Mol Cell Cardiol; 2013 Mar; 56():72-80. PubMed ID: 23274063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.